DelistingNov 12, 2026, 06:14 AM
AtlasClear Holdings to be Delisted from NYSE American; Plans Appeal
AI Summary
AtlasClear Holdings, Inc. received a notice from NYSE American of the suspension of trading and commencement of delisting proceedings for its common stock, citing a low selling price. The company intends to appeal this decision and expects its stock to trade on the OTC market during the appeal process. Despite the delisting notice, AtlasClear emphasized that its core clearing operations remain compliant with regulatory requirements and are progressing, with eight correspondent broker-dealer agreements signed. The company also reported an 85% revenue increase to $20.1 million in fiscal 2026.
Key Highlights
- NYSE American has suspended trading of AtlasClear Holdings, Inc. common stock and initiated delisting proceedings due to low stock price.
- AtlasClear intends to appeal the NYSE American's determination to the Listings Qualifications Panel.
- The company's common stock is expected to trade on the OTC Pink Limited Market under the symbol 'ATCH' during the appeal process.
- AtlasClear's underlying business operations and regulatory net capital compliance remain unaffected.
- AtlasClearing, Inc. has signed eight correspondent broker-dealer agreements, with onboarding ongoing.
- AtlasClear's fiscal 2026 revenue increased 85% to $20.1 million, with cash doubling to $15.4 million.
Price Impact
More from ATCH